New hope for advanced cancer: experimental drug AWT020 enters human trials
Disease control
Recruiting now
This early-stage trial tests a new drug, AWT020, in about 60 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goals are to check the drug's safety at different doses and to see how the body processes it. This study does not aim…
Phase: PHASE1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated May 22, 2026 13:52 UTC